PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Title only   |   Print    Next page > 
     
EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services
PROVIDENCE, R.I. , June 23, 2026 /PRNewswire/ -- EpiVax, Inc., a recognized leader in immunogenicity risk assessment, announces the expansion of its laboratory facilities at its Providence, RI headquarters. ...
2026-06-23T    Health Care/Hospital   Medical/Pharmaceuticals 
TriNetX LIVE™ Network Surpasses 300 Million Patients, Expanding Decision-Grade Evidence Across Global Healthcare
The milestone reflects accelerating international growth and gives pharmaceutical companies, academic researchers, healthcare providers, and health-tech innovators access to trusted, current, clinically ...
2026-06-23T    Computer/Electronics   Health Care/Hospital 
Ambulatory Surgical Centres Poised for Sustained Growth as Healthcare Delivery Continues to Shift Beyond the Hospital
Frost & Sullivan identifies significant opportunities across ambulatory surgery, digital health, and connected care markets ...
2026-06-23T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
BedStory® Launches BEDSTORY SPINEALIGN® and Cooling Collection Sleep Systems as Demand Grows for Precision-Tuned Support and Cooler Sleep
FOLSOM, Calif. , June 23, 2026 /PRNewswire/ -- In response to growing consumer demand for sleep solutions that support both healthy sleep posture and thermal comfort, BedStory®, a family-focused ...
2026-06-23T    Furniture & Furnishings   Health Care/Hospital   Household/Consumer/Cosmetics 
Fair Play Menarini International Award
Diego Milito and Emilio Butragueño among the winners of the 30th edition ...
2026-06-23T    Health Care/Hospital   Medical/Pharmaceuticals 
Ascletis Announces U.S. FDA IND Clearance for Phase I Study of Once-Monthly Subcutaneously Administered GLP-1R/GIPR Dual Peptide Agonist, ASC35, for the Treatment of Obesity
Phase I trial consists of two parts. Part A is a single ascending dose (SAD) study of ASC35 once-monthly Self-Assembling Lipid Depot (SALD) formulation; Part B is a head-to-head study of multiple ascending ...
2026-06-23T    Health Care/Hospital   Medical/Pharmaceuticals 
WONTECH ASIA, THAILAND, Korean aesthetics leader, tops THB1bn revenue, up 39% with 40%+ RF market share; WAVE BANGKOK 2026 to spotlight Thailand's medical potential globally
BANGKOK , June 23, 2026 /PRNewswire/ -- Thailand's beauty market, particularly the plastic surgery and aesthetic sector, was valued at approximately 75 billion baht in 2025. According to data from the ...
2026-06-23T    Cosmetics & Personal Care   Health Care/Hospital   Household/Consumer/Cosmetics 
CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation
SEOUL, South Korea , June 23, 2026 /PRNewswire/ -- Informa Markets Korea has officially opened pre-registration for CPHI/ Hi Korea 2026, taking place at COEX, Seoul, from August 25 to 27. Pre-registered ...
2026-06-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
DoH and Sanofi Partner to Advance Vaccine Innovation
ABU DHABI, UAE , June 23, 2026 /PRNewswire/ -- The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, and Sanofi, a worldwide biopharma and vaccines leader, ...
2026-06-23T    Health Care/Hospital   Medical/Pharmaceuticals 
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
MELBOURNE, Australia and INDIANAPOLIS , June 23, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces an educational webinar exploring the unmet ...
2026-06-23T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.